Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome.
about
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesBrain-gut microbiome interactions and functional bowel disordersGut microbiota as potential orchestrators of irritable bowel syndromeFactors associated with obesity in Iranian elderly people: results from the national health surveyThe combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.The intestinal microbiome, probiotics and prebiotics in neurogastroenterology.Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease?Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?Wuji Wan Formula Ameliorates Diarrhea and Disordered Colonic Motility in Post-inflammation Irritable Bowel Syndrome Rats by Modulating the Gut Microbiota.Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies.The gut microbiome and irritable bowel syndrome.
P2860
Q26768550-09E8CAF6-A787-4C70-849A-6F566E9654E0Q27014531-541BA5FE-0960-4047-9EA1-E242DE4994CDQ28085584-0956C306-0F0C-4305-8A84-6432E1E56F39Q28396382-063C6DE6-D763-4910-B737-02CD1937B390Q33468382-D9D93701-2F4C-425D-9DF3-515950FE4023Q36564707-F0777A74-F9EA-475E-A169-5EEED00914F6Q38320437-F524AA05-1030-4DC5-906F-E41F8B31BFA7Q38970657-CA79F254-B9F1-44A1-8FD7-319AA7BB0B10Q41849440-8BDB4DC3-4D5A-402A-A4E9-30329D01EC3CQ47124809-AB6689C2-B8AA-4573-B1D2-88C1CED84477Q50193587-48AEB937-9841-4D88-B653-2AF10A9AD73AQ54263480-41FAC4EA-A7AA-48CD-82ED-DC9818BFFC00Q55716608-BAB2E7D6-BBE4-4A8E-8066-0A68F670A832
P2860
Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Efficacy, safety, and tolerabi ...... t of irritable bowel syndrome.
@ast
Efficacy, safety, and tolerabi ...... t of irritable bowel syndrome.
@en
type
label
Efficacy, safety, and tolerabi ...... t of irritable bowel syndrome.
@ast
Efficacy, safety, and tolerabi ...... t of irritable bowel syndrome.
@en
prefLabel
Efficacy, safety, and tolerabi ...... t of irritable bowel syndrome.
@ast
Efficacy, safety, and tolerabi ...... t of irritable bowel syndrome.
@en
P356
P1476
Efficacy, safety, and tolerabi ...... t of irritable bowel syndrome.
@en
P2093
E Gudmand-Hoyer
P304
P356
10.1093/AJCN/72.6.1570
P407
P577
2000-12-01T00:00:00Z